Eyenovia, Inc.
NASDAQ:EYEN
0.09 (USD) • At close January 14, 2025
Overzicht | Financiële gegevens
Bedrijfsnaam | Eyenovia, Inc. |
Symbool | EYEN |
Munteenheid | USD |
Prijs | 0.086 |
Beurswaarde | 9,582,550 |
Dividendpercentage | 0% |
52-weken bereik | 0.077 - 2.57 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Mr. Michael M. Rowe |
Website | https://www.eyenovia.com |
An error occurred while fetching data.
Over Eyenovia, Inc.
Eyenovia, Inc., a clinical stage ophthalmic company, engages in developing therapeutics based on its proprietary microdose array print platform technology. The company focuses on developing clinical microdosing of formulations of ophthalmic pharmaceutical agents using its Optejet branded targeted ocular delivery system. It focuses on the development of therapeutic indications for
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)